Specific Biologics

Series-A
specificbiologics.com Biotech & Healthcare Toronto
Total Funding $35M
Latest Round $35M Series-A
Last Announced Nov 2, 2026
Investors 5 Backers
Decision Makers 5 Available

About Specific Biologics

Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Toronto
Tracked Since Nov 2, 2026

Web & Domain Identity

Official Website specificbiologics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @SpecificBio
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $35,000,000 · Series-A

    app.dealroom.co

  2. Capital Raise

    Seed announced

    Backed by Lumira Ventures

Investors & Backers

5
Lumira Ventures
Lead
adMare Bio Innovations
Creative Destruction Lab
Genome Canada
Ontario Genomics

Funding History

2 Rounds
Series-A equity · Nov 2, 2026
$35,000,000 app.dealroom.co
Seed equity · Dec 16, 2021

Round backers: Lumira Ventures

Undisclosed prnewswire.com

Founders & Leadership

2

Brent Stead

Founder

Work email & phone locked Unlock →

Odi Israel

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts